Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Highlights

Highlights August 2017 In This Issue Volume 153, Number 8 Pages 733-840 JAMA Dermatology Clinical Review & Education Research JAMA Dermatology Medicare Part D Payments for Topical Steroids 755 Clinicopathological Challenge Rising US pharmaceutical costs are a source of increasing fi nancial burden for payers and patients. Increased pharmaceutical costs are often attributed to novel agents that require funding for development and testing. In this retrospective cost analysis of Medicare Part D participants who fi lled prescriptions for topical steroids, Song et al demonstrate that most topical steroids prescribed were generic drugs. The sharp increase in Medicare and out-of- pocket spending on topical steroids has been driven by higher costs for generics. Clinical decision support tools to enable lower-cost generic topical steroid substitutions from the corresponding potency class may reduce drug expenditures. Editorial 745 817 What is your diagnosis? Continuing Medical Education jamanetwork.com/learning 837 Correction Prevalence Estimates for Hidradenitis Suppurativa 760 Hidradenitis suppurativa (HS) is a debilitating, painful chronic infl ammatory disease for HUMANITIES which sparse epidemiologic data exist. The inherent unpredictability with respect to dis- Notable Notes ease course and response to treatment poses signifi cant challenges for patients. In this 744 Skin Suff ocation retrospective case cohort analysis, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Highlights

JAMA Dermatology , Volume 153 (8) – Aug 1, 2017

Highlights

Abstract

August 2017 In This Issue Volume 153, Number 8 Pages 733-840 JAMA Dermatology Clinical Review & Education Research JAMA Dermatology Medicare Part D Payments for Topical Steroids 755 Clinicopathological Challenge Rising US pharmaceutical costs are a source of increasing fi nancial burden for payers and patients. Increased pharmaceutical costs are often attributed to novel agents that require funding for development and testing. In this retrospective cost analysis of Medicare Part D...
Loading next page...
 
/lp/american-medical-association/highlights-dUW6qG1i0I
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/jamadermatol.2016.1700
Publisher site
See Article on Publisher Site

Abstract

August 2017 In This Issue Volume 153, Number 8 Pages 733-840 JAMA Dermatology Clinical Review & Education Research JAMA Dermatology Medicare Part D Payments for Topical Steroids 755 Clinicopathological Challenge Rising US pharmaceutical costs are a source of increasing fi nancial burden for payers and patients. Increased pharmaceutical costs are often attributed to novel agents that require funding for development and testing. In this retrospective cost analysis of Medicare Part D participants who fi lled prescriptions for topical steroids, Song et al demonstrate that most topical steroids prescribed were generic drugs. The sharp increase in Medicare and out-of- pocket spending on topical steroids has been driven by higher costs for generics. Clinical decision support tools to enable lower-cost generic topical steroid substitutions from the corresponding potency class may reduce drug expenditures. Editorial 745 817 What is your diagnosis? Continuing Medical Education jamanetwork.com/learning 837 Correction Prevalence Estimates for Hidradenitis Suppurativa 760 Hidradenitis suppurativa (HS) is a debilitating, painful chronic infl ammatory disease for HUMANITIES which sparse epidemiologic data exist. The inherent unpredictability with respect to dis- Notable Notes ease course and response to treatment poses signifi cant challenges for patients. In this 744 Skin Suff ocation retrospective case cohort analysis,

Journal

JAMA DermatologyAmerican Medical Association

Published: Aug 1, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month